A clinical and pharmacokinetic study of isolated limb perfusion with heat and melphalan for melanoma

94Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The pharmacokinetics of isolated limb perfusion were studied to see what melphalan concentrations were achieved and how effective the isolation was. Twenty‐eight patients received 32 limb perfusions with heat and melphalan for locally recurrent or level V melanoma. Melphalan was given 0.75 mg/kg for axillary/popliteal or 1.2 mg/kg for femoral perfusions with heat (perfusate 42°C, limb 40°C) for 1 hour. Melphalan concentratives were measured by high‐performance liquid chromatography in seven patients. Peak perfusate melphalan concentrations were 6.1 to 115 mg/ml, which was one to two logs higher than peak systemic concentratives of melphalan. Isolation of the perfusate circuit from the systemic circulation was better for axillary and popliteal perfusions than for femoral perfusions (P < 0.05). Complete responses were seen in 81% of evaluable patients; long‐term local control was achieved in most patients, although many developed hematogenous metastases. Toxicity included erythema and edema in all, mild leukopenia in two, neuropathy in two, and amputation was required in one patient. Improvements in surgical technique include regional anesthesia to reduce vasospasms and transcutaneous measurement of fluorescein to measure leak. Perfusion with heat and melphalan remains the treatment of choice for in‐transit metastases from melanoma. Copyright © 1985 American Cancer Society

References Powered by Scopus

Chemotherapy of cancer: regional perfusion utilizing an extracorporeal

638Citations
N/AReaders
Get full text

Marrow autotransplantation accelerates haematological recovery in patients with malignant melanoma treated with high-dose melphalan

118Citations
N/AReaders
Get full text

Oral melphalan kinetics

92Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Current uses of isolated limb perfusion in the clinic and a model system for new strategies

209Citations
N/AReaders
Get full text

Randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone compared with melphalan plus tumor necrosis factor: American College of Surgeons Oncology Group trial Z0020

203Citations
N/AReaders
Get full text

HSP70 protects against TNF-induced lethal inflammatory shock

173Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Minor, D. R., Allen, R. E., Alberts, D., Peng, Y. ‐M, Tardelli, G., & Hutchinson, J. (1985). A clinical and pharmacokinetic study of isolated limb perfusion with heat and melphalan for melanoma. Cancer, 55(11), 2638–2644. https://doi.org/10.1002/1097-0142(19850601)55:11<2638::AID-CNCR2820551118>3.0.CO;2-E

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 5

56%

Researcher 4

44%

Readers' Discipline

Tooltip

Medicine and Dentistry 3

43%

Agricultural and Biological Sciences 2

29%

Chemistry 1

14%

Nursing and Health Professions 1

14%

Save time finding and organizing research with Mendeley

Sign up for free